Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950123-11-001650
Filing Date
2011-01-10
Accepted
2011-01-10 09:01:01
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM S-3 y04358sv3.htm S-3 187096
2 EX-5.1 y04358exv5w1.htm EX-5.1 6726
3 EX-23.1 y04358exv23w1.htm EX-23.1 1552
4 GRAPHIC y04358y0435801.gif GRAPHIC 1681
  Complete submission text file 0000950123-11-001650.txt   199462
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-171615 | Film No.: 11518932
SIC: 2836 Biological Products, (No Diagnostic Substances)